Transaction Details

Footnotes

Received in exchange for 36,311,022 shares of the common stock of Ionetix Corporation, a privately held Delaware corporation ("Target"), in connection with the merger (such transaction, the "Merger") of JDEV Merger Subsidiary Corp. ("Merger Sub"), a wholly-owned subsidiary of JDEV Acquisition Corp. (such entity, which changed its name to Ionetix Corporation in connection with the Merger, the "Issuer"), with and into Target, pursuant to that certain Agreement and Plan of Merger and Reorganization dated as of April 9, 2026 by and among the Issuer, Target and Merger Sub. | Ospraie Management, LLC ("OM LLC") is the investment manager of Ospraie Real Assets Fund LP ("ORA Fund") and has been delegated voting and investment power and thus beneficial ownership of the securities of the Issuer held by ORA Fund (such securities, the "Issuer Securities"). Ospraie Holding I, LP ("Ospraie Holding") may be deemed to beneficially own the Issuer Securities as the managing member of OM LLC. | Ospraie Management, Inc. ("OM Inc.") may be deemed to beneficially own the Issuer Securities as the general partner of Ospraie Holding. Ospraie Real Assets GP LLC ("Ospraie GP") may be deemed to beneficially own the Issuer Securities as the general partner of ORA Fund. Dwight Anderson may be deemed to beneficially own the Issuer Securities as the managing member of Ospraie GP and as the sole owner of OM Inc. Each reporting person disclaims beneficial ownership of the Issuer Securities except to the extent of his or its pecuniary interest therein, if any. | Received in the Merger in exchange for a warrant to purchase 2,625,000 shares of Target common stock at an exercise price of $1.40 per share. | Received in the Merger in exchange for a warrant to purchase 1,072,500 shares of Target common stock at an exercise price of $1.40 per share. | Received in the Merger in exchange for a warrant to purchase 6,443,076 shares of Target common stock at an exercise price of $0.01 per share. This warrant contains a provision that restricts the ability of the holder to exercise the warrant to the extent that, after giving effect to the issuance of shares of the common stock of the Issuer upon such exercise, the holder would beneficially own in excess of 19.9% of the number of outstanding shares of the Issuer's common stock.